Stock listing

Munich:8EM Editas Medicine, Inc. Aktie

German listing (Munich) of Editas Medicine, Inc. · home listing NASDAQ:EDIT

Follow Editas Medicine, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:EDIT

$2.35 USD -0.09 (-3.7%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:EDIT

Since Jul 6, 2026 -35.6% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$2.33 – $2.47 USDOct 16, 2026
Volume
1.55M sharesOct 16, 2026
Market value
$360.9M USDAt the close on Oct 16, 2026 · price × 153.6M shares outstanding
Editas Medicine, Inc. logo
Ticker
Munich:8EM
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Munich
Currency
EUR

What changed lately

Calls

Replays

  • Editas Medicine (NASDAQ:EDIT) Q2 2024 Earnings Call

    Wed, Aug 07, 2024 · 8:00 AM ET

    Watch Transcript
  • Editas Medicine (NASDAQ:EDIT) Q1 2024 Earnings Call

    Wed, May 08, 2024 · 8:00 AM ET

    Watch Transcript
  • Editas Medicine (NASDAQ:EDIT) Q4 2023 Earnings Call

    Wed, Feb 28, 2024 · 8:00 AM ET

    Watch Transcript

Latest news

All Editas Medicine, Inc. news

Decks

Editas Medicine, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
16 in the last 12 months · 187 in all · newest Oct 14, 2026 · oldest 2019
Calls
16 calls with a replay · 16 with a transcript · latest Aug 7, 2024
Decks
25 decks · latest June 2026

Where Editas Medicine, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:EDIT · Home listingNASDAQUnited StatesUSD
gettex:8EMgettexGermanyEUR
BOATS:EDITBOATSUnited StatesUSD
Tradegate:8EMTradegateGermanyEUR
LS Exchange:A2AC4KLS ExchangeGermanyEUR
Stuttgart:8EMStuttgartGermanyEUR
Lang & Schwarz:A2AC4KLang & SchwarzGermanyEUR
LSE:0IFKLSEUnited KingdomUSD
Frankfurt:8EMFrankfurtGermanyEUR
BX Swiss:8EMBX SwissSwitzerlandCHF
Dusseldorf:8EMDusseldorfGermanyEUR
Hamburg:8EMHamburgGermanyEUR
Munich:8EM · This pageMunichGermanyEUR

Log in to ask 6ix AI your own questions about Editas Medicine, Inc.